Skip to main content
. 2016 Jun 16;2016(6):CD011889. doi: 10.1002/14651858.CD011889.pub2

Gatoulis 2012.

Methods R, DB, AC, and PC, parallel groups
1 episode treated with a single dose of study medication when pain was ≥ mod intensity
Participant diary
Participants Episodic TTH (IHS), 2‐10 episodes/month. Able to distinguish from migraine
Excl: known allergy to study interventions, previous non‐response to active interventions, significant medical history, recent head injury
n = 559 (safety population), 487 (efficacy)
M 183, F 304
Mean age 37 years (range 18‐66 years)
Baseline PI: 76% mod, 24% severe
Interventions Paracetamol 300 mg + codeine 30 mg, n = 233
Aspirin 1000 mg, n = 223
Placebo, n = 103
Rescue medication (usual treatment) allowed. No timing given
Outcomes PI: 4‐point scale (0.5, 1, 2, 3, 4 5, 6 h)
PR: 5‐point scale
Notes Oxford Quality Score: R1, DB2, W1
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Individuals were randomly assigned". Method of sequence generation not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double dummy method
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Double dummy method
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk 7‐14% attrition. Imputation method not reported
Size Unclear risk 50‐200 participants in each treatment arm (103‐233)